Clinical Trials Insight: 700042652
Phase of Trial: Phase I
Latest Information Update: 31 Oct 2009
At a glance
- Drugs Granisetron (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Adverse reactions
- Sponsors Solasia Pharma
- 31 Oct 2009 Status changed from recruiting to completed, according to a Solasia Pharma media release.
- 19 Mar 2009 New trial record.